-
-
-
-
-
-
-
Ligand Pharma (LGND) Reiterated at Buy by Stifel After Chat With CEO, CFO
-
-
-
-
-
-
-
XOMA Royalty Announces Closing of Its Acquisition by Ligand
-
-
-
-
-
-
-
Ligand plans $550M convertible notes offering due 2031
-
-
-
-
-
-
-
Ligand to acquire XOMA Royalty for $739 million in cash deal
-
-
-
-
-
-
-
Ligand Pharma (LGND) PT Raised to $167 at Oppenheimer
-
-
-
-
-
-
-
Ligand Announces Completion of Pelthos Therapeutics Merger with Channel Therapeutics
-
-
-
-
-
-
-
Ligand Reports Third Quarter 2024 Financial Results and Raises 2024 Guidance
-
1,200,819 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


